1.

In November 2020, whose experimental COVID-19 vaccine has received a fast-track designation from U.S. regulators?

A. Moderna
B. Pfizer
C. Novavax Inc.
D. Emergent BioSolutions
E. Novartis
Answer» D. Emergent BioSolutions


Discussion

No Comment Found